Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens
- 1 January 1997
- Vol. 49 (1) , 71-78
- https://doi.org/10.1016/s0090-4295(96)00325-1
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Short-term versus long-term addition of cyproterone acetate to buserelin therapy in comparison with orchidectomy in the treatment of metastatic prostate cancerCancer, 1993
- Combination treatment in M1 prostate cancerCancer, 1993
- Orchiectomy and Nilutamide or Placebo as Treatment of Metastatic Prostatic Cancer in a Multinational Double-Blind Randomized TrialJournal of Urology, 1993
- A general parametric approach to the meta‐analysis of randomized clinical trialsStatistics in Medicine, 1991
- A Controlled Trial of Castration With and Without Nilutamide in Metastatic Prostatic CarcinomaCancer, 1990
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trialsJAMA, 1986
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981